๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Morphological predictors of survival in colorectal carcinoma: Univariate and multivariate analysis

โœ Scribed by P. Schmitz-Moormann; G. W. Himmelmann; U. Baum; M. Nilles

Book ID
112293862
Publisher
Springer-Verlag
Year
1987
Tongue
English
Weight
1007 KB
Volume
113
Category
Article
ISSN
1432-1335

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Lymph node involvement correlation with
Lymph node involvement correlation with survival in advanced gastric carcinoma: Univariate and multivariate analyses
โœ Shouji Shimoyama; Michio Kaminishi; Yoshiaki Joujima; Takeshi Oohara; Chikuma Ha ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 496 KB

## Abstract The aim of this study was to elucidate what factors affect the survival of patients with advanced gastric carcinoma. The relationship between the survival of 282 patients over a period of 15 years and 12 prognostic factors was investigated. In univariate analysis, lymph node involvement

Factors predicting survival in stage IV
Factors predicting survival in stage IV colorectal carcinoma patients after palliative treatment: A multivariate analysis
โœ Sigmar Stelzner; Gunter Hellmich; Rainer Koch; Klaus Ludwig ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 79 KB

## Background: The prognostic impact of primary tumor resection in patients presenting with unresectable synchronous metastases from colorectal carcinoma (crc) is not well established. in the present study, we analyzed fifteen factors to define the value of primary tumor resection with regard to pr

Lipiodolization for unresectable hepatoc
Lipiodolization for unresectable hepatocellular carcinoma: An analysis of 205 patients using univariate and multivariate analysis
โœ Keiko Urata; Takashi Matsumata; Tatsuro Kamakura; Kanehiro Hasuo; Keizo Sugimach ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 458 KB

Since 1982 we have developed and successfully performed lipiodolization on 205 patients with unresectable hepatocellular carcinoma. The 1-, 2-, 3-, 4-, and 5-year survival rates were 55.6%, 31.7%, 16.3%, 8.7%, and 2.9%, respectively, while the median survival was 413 days, and 20 patients survived l